Vireo Growth (VREOF) EBT (2020 - 2026)
Vireo Growth (VREOF) reported EBT of -$4.2 million for Q1 2026, up 12.5% on a YoY basis from -$3.7 million in Q1 2025, and up 65.13% sequentially from -$12.0 million in Q4 2025.
Vireo Growth (VREOF) EBT (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of EBT data on file, last reported at -$4.2 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 12.5% year-over-year to -$4.2 million; the trailing twelve-month figure through Mar 2026 stood at -$39.3 million (down 107.51% YoY), and the FY2025 full-year result was -$39.9 million, down 136.24% from the prior year.
- EBT grew to -$4.2 million in Q1 2026, from -$12.0 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$228411.0 in Q2 2024 to a low of -$16.3 million in Q1 2022.
- A 5-year average of -$6.8 million and a median of -$5.7 million in 2023 frame the typical range for EBT.
- Across the five-year window, EBT jumped 96.02% in 2024 and sank 4313.11% in 2025, its largest moves.
- Tracing VREOF's EBT over 5 years: stood at -$7.3 million in 2022, then soared by 51.0% to -$3.6 million in 2023, then slumped by 215.97% to -$11.4 million in 2024, then fell by 6.05% to -$12.0 million in 2025, then soared by 65.13% to -$4.2 million in 2026.
- Business Quant data shows VREOF's EBT at -$4.2 million in Q1 2026, -$12.0 million in Q4 2025, and -$13.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 437.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 758.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.90 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 318.30 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -247.30 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 246.80 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 87.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -4.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.20 Mn |
| Dec 31, 2025 | -12.05 Mn |
| Sep 30, 2025 | -12.95 Mn |
| Jun 30, 2025 | -10.08 Mn |
| Mar 31, 2025 | -4.80 Mn |
| Dec 31, 2024 | -11.36 Mn |
| Sep 30, 2024 | -2.54 Mn |
| Jun 30, 2024 | -228,411.00 |
| Mar 31, 2024 | -2.77 Mn |
| Dec 31, 2023 | -3.59 Mn |
| Sep 30, 2023 | -1.75 Mn |
| Jun 30, 2023 | -5.74 Mn |
| Mar 31, 2023 | -6.74 Mn |
| Dec 31, 2022 | -7.34 Mn |
| Sep 30, 2022 | -7.78 Mn |
| Jun 30, 2022 | -5.14 Mn |
| Mar 31, 2022 | -16.31 Mn |
| Dec 31, 2021 | -11.78 Mn |
| Sep 30, 2021 | -6.31 Mn |
| Jun 30, 2021 | -6.10 Mn |